Top News

White House Sets Medicare Price Negotiation Targets

August 31, 2023

The Centers for Medicare & Medicaid Services (CMS) has announced the first 10 drugs covered under Medicare Part D selected for negotiation.

Danaher to Acquire Abcam in $5.7 Billion Deal

August 29, 2023

Danaher intends to acquire Abcam, a provider of life sciences assays and reagents, for $5.7 billion.

Lilly Completes Spate of Acquisitions

August 15, 2023

The completion of three acquisitions of Versanis Bio, Sigilon Therapeutics, and DICE Therapeutics boosts Eli Lilly and Company’s product pipeline in obesity, diabetes, and immunology.

Novartis Finalizes Chinook Therapeutics Acquisition in Deal Worth Up to $3.5 Billion

August 11, 2023

Novartis has completed its acquisition of biopharma company Chinook Therapeutics.

Biogen to Acquire Reata Pharmaceuticals for $7.3 Billion

August 01, 2023

Biogen’s acquisition of Reata will grant them access to Reata’s FDA-approved treatment for Friedreich’s ataxia.

Sandoz Spin-off Gets Green Light from Novartis Board

July 21, 2023

The proposed spin-off of Sandoz into an independent entity has been approved by Novartis’ board of directors.

Novartis Acquires DTx Pharma in Deal Worth Up to $1 Billion

July 20, 2023

Novartis’ acquisition of biotech company DTx Pharma boosts its neuroscience pipeline and expands its capabilities in RNA-based therapeutics.

Merck Files Lawsuit Against US Government

June 08, 2023

The complaint alleges that Medicaid price controls implemented in the Inflation Reduction Act will negatively impact biopharmaceutical innovation.

UK Government Boosts AMR Research with Cash Injection

May 24, 2023

UK government supports AMR research with significant cash injection, provided through the Global AMR Innovation Fund (GAMRIF).

Waters Set for Growth in Bioanalytical Characterization with Wyatt Acquisition

May 18, 2023

Waters Corporation expected to boost growth in bioanalytical characterization for new modalities with acquisition of Wyatt Technology.